Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy

PURPOSE: Eradication of chronic hepatitis C virus (HCV) after interferon-based therapy and its association with the reduction of risk of hepatocellular carcinoma (HCC) in HCV-infected patients with advanced fibrosis is controversial. The study is aimed to develop a simple scoring model for HCC predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ching-Chih, Weng, Cheng-Hao, Chang, Liang-Che, Lin, Chih-Lang, Chen, Yen-Ting, Hu, Ching-Fang, Hua, Man-Chin, Chen, Li-Wei, Chien, Rong-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933468/
https://www.ncbi.nlm.nih.gov/pubmed/29750037
http://dx.doi.org/10.2147/TCRM.S158424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933468/
https://www.ncbi.nlm.nih.gov/pubmed/29750037
http://dx.doi.org/10.2147/TCRM.S158424

Ejemplares similares